SCHEMBL24967246

SCHEMBL24967246

Cc1ncc(-c2ccc3c(c2)c(C(C)O)nn3CC(C)(C)C)cn1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CFD P00746 18/20 0.46
DYRK1A Q13627 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24967370 0.84 CYP4F2 (0.43) CFD
SCHEMBL25096901 0.77 CFD (0.43) CFDDYRK1A
SCHEMBL24967790 0.76 CFD (0.46) CFD
SCHEMBL21159191 0.73 CFD (0.42) CFDDYRK1A
SCHEMBL24966631 0.72 CFD (0.40) CFD
SCHEMBL21159405 0.72 CFD (0.40) CFDDYRK1A
SCHEMBL20992364 0.72 CFD (0.40) CFDDYRK1A
SCHEMBL22355142 0.71 CFD (0.54) CFD
SCHEMBL18555722 0.71 CFD (0.54) CFD
SCHEMBL20297048 0.71 CFD (0.72) CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022157-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022157-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS CFD, CFH, TFPI CFD 1/4885DYRK1A 4149/4885PRMT5 4488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.